---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-24-000034"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:43:50.578062+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical pre-announces Q2 revenue $195.9M (+30% YoY), raises 2024 guidance to $788-798M

## Summary
- Q2 revenue $195.9M, up 30% YoY; US revenue $187.8M (+30%), OUS $8.1M (+27%).
- Full-year 2024 revenue guidance raised to $788-798M, up $13M from prior $775-785M range.
- Management cites strong execution and sequential US revenue growth acceleration.
- Complete Q2 results and earnings call scheduled for August 6, 2024.

## SEC filing metadata
- accession: 0001609550-24-000034
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/0001609550-24-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/insp-20240729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-24-000034
- JSON: https://secwatch.observer/filing/0001609550-24-000034.json
- Plain text: https://secwatch.observer/filing/0001609550-24-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.